AI Summary

Research shows cancer clinical trial participants incurred a median reimbursement of $2,128 for non‑medical expenses, highlighting financial burdens tied to socioeconomic and logistical factors. The findings, published in the journal CANCER by Wiley, call for improved reimbursement programs to promote equitable trial access and retain participants.

AI summaries can be wrong sometimes—always verify important details using the source article.